@NabilahMayat @Jopo_dr @FranDenham Proning has several effects on pulmonary physiology beyond oxygenation (which isn't a perfect surrogate for mortality in ARDS studies). It's not clear which effects drive the observed mortality benefit in RCTs. Excellent review here: https://t.co/hs4LLjeaVV
Treatment of ARDS With Prone Positioning.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2020 – Oct 2022Where it's discussed
-
News15 articles
-
X / Twitter12 posts
-
Facebook8 posts
-
YouTube4 videos
-
Blogs2 articles
AI synopsis
What people are saying
The group's analysis emphasizes the clinical significance of prone positioning, referencing key studies such as PROSEVA and discussing details like the optimal duration of prone sessions. The tone varies from informative to curious, with some posts questioning the mechanisms behind observed benefits, indicating a balanced but moderate level of depth and concern for the treatment's implications.
Most discussions acknowledge the benefits of prone positioning, particularly referencing studies like PROSEVA that show mortality reductions.
Participants show a moderate level of curiosity, mainly focusing on treatment duration and physiological effects, but not deeply exploring implications.
Posts include references to specific trials and physiological effects, indicating some in-depth engagement with the research.
The discussions highlight the importance of the treatment and its potential to influence clinical practices, but with limited advocacy or controversy.
Abstract in brief
- Prone positioning began in the 1970s as a way to improve oxygen exchange in ARDS patients, showing initial promise through physiological improvements in gas exchange.
- While early research demonstrated physical and respiratory benefits, translating those into clear clinical improvements was difficult, with many trials showing limited effects.
- Recent studies like the PROSEVA trial found that early application of prone positioning, combined with other lung-protective approaches, significantly reduces mortality in severe ARDS cases.]
Top posts
Most liked on X and BlueskyReferences: Scholten EL, Beitler JR et al. Treatment of ARDS With Prone Positioning. Chest, 2017 January; 151(1): 215–224 PROSEVA trial: Guérin C., Reignier J., Richard J.C. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168
Treatment of ARDS With Prone Positioning https://t.co/X7OS1ic4Ge
How long should you prone? Mean duration in PROSEVA trial was 4 days, some argue that we should go longer https://t.co/om7sqeSCDZ
Treatment of ARDS With Prone Positioning https://t.co/A1b45EYHlc
@OccupyDisabled @UNMC_DrKhan Another external pressure treatment that's being used to help people... Treatment of ARDS With Prone Positioning https://t.co/t7J2wLlWI7
All mentions
Prone Positioning in ARDS: Techniques and Clinical Benefits
This video explains the effects of prone positioning on ARDS patients, highlighting its physiological benefits, early research findings, and recent evidence demonstrating its role in reducing mortality when applied…
ARDS Management and Prone Positioning Strategies in Critical Care
Acute respiratory distress syndrome involves lung injury leading to fluid in the air spaces. Ventilatory management employs lung protective strategies, with prone positioning shown to improve oxygenation and reduce…
Understanding SARS-CoV-2 Vaccines and Immune Response Mechanisms
This video explains the mechanisms by which COVID-19 vaccines generate immunity, highlighting ongoing scientific research and the importance of vaccines in combating the virus. It acknowledges the contributions of…
Understanding SARS-CoV-2 Diagnosis and COVID-19 Overview
This video simplistically explains the diagnosis and disease caused by SARS-CoV-2. It highlights the complexity of the virus and its diagnosis, emphasizing the importance of scientific research and expert insights to…
RT @niven_alex: How long should you prone? Mean duration in PROSEVA trial was 4 days, some argue that we should go longer https://t.co/om7…
How long should you prone? Mean duration in PROSEVA trial was 4 days, some argue that we should go longer https://t.co/om7sqeSCDZ
RT @AartikSarma: @NabilahMayat @Jopo_dr @FranDenham Proning has several effects on pulmonary physiology beyond oxygenation (which isn't a p…
@NabilahMayat @Jopo_dr @FranDenham Proning has several effects on pulmonary physiology beyond oxygenation (which isn't a perfect surrogate for mortality in ARDS studies). It's not clear which effects drive the observed mortality benefit in RCTs. Excellent review here: https://t.co/hs4LLjeaVV
Treatment of ARDS With Prone Positioning https://t.co/X7OS1ic4Ge
RT @BEMSbirmingham: References: Scholten EL, Beitler JR et al. Treatment of ARDS With Prone Positioning. Chest, 2017 January; 151(1): 215–2…
References: Scholten EL, Beitler JR et al. Treatment of ARDS With Prone Positioning. Chest, 2017 January; 151(1): 215–224 PROSEVA trial: Guérin C., Reignier J., Richard J.C. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168
@OccupyDisabled @UNMC_DrKhan Another external pressure treatment that's being used to help people... Treatment of ARDS With Prone Positioning https://t.co/t7J2wLlWI7
RT @Cometin007: Treatment of ARDS With Prone Positioning https://t.co/A1b45EYHlc
RT @Cometin007: Treatment of ARDS With Prone Positioning https://t.co/A1b45EYHlc
Treatment of ARDS With Prone Positioning https://t.co/A1b45EYHlc
Treatment of ARDS With Prone Positioning https://t.co/14RqzON5bz